Ngenla 60 mg | Somatrogon 60 mg/1.2 ml Pen

Ngenla 60 mg Pen: Pfizer Somatrogon Product Overview

Ngenla 60 mg Pen by Pfizer is a long-acting growth hormone analog containing somatrogon-ghla, a recombinant protein developed for once-weekly treatment of pediatric growth hormone deficiency. Each prefilled injection pen contains 60 mg of somatrogon in 1.2 ml of solution, providing a concentration of 50 mg/ml.

Unlike conventional human growth hormone (HGH) medications containing somatropin, Ngenla uses somatrogon-ghla, a modified growth hormone molecule with extended activity. This distinction is important when comparing Ngenla with other growth hormone products.

The historical catalog name "Ngenla 180IU" is retained for product identification. However, Pfizer officially identifies this presentation as Ngenla 60 mg/1.2 ml. The legacy IU designation is not an approved conversion to somatropin international units.

Ngenla 60 mg/1.2 ml Product Specifications

• Product Name: Ngenla 60 mg Pen
• Legacy Catalog Name: Ngenla 180IU
• Brand: Ngenla
• Manufacturer: Pfizer
• Active Ingredient: Somatrogon-ghla
• Classification: Long-acting growth hormone analog
• Total Strength: 60 mg
• Solution Volume: 1.2 ml
• Concentration: 50 mg/ml
• Pharmaceutical Form: Solution for injection
• Delivery Format: Prefilled injection pen
• Package Configuration: 1 pen x 60 mg/1.2 ml
• Dose Increments: 0.5 mg
• Maximum Single Injection: 30 mg
• Administration Route: Subcutaneous injection
• Treatment Schedule: Once weekly when prescribed
• Storage: Refrigerated at 2°C–8°C
• Prescription Status: Prescription medication

Ngenla Active Ingredient: Somatrogon-ghla

The active ingredient in Pfizer Ngenla is somatrogon-ghla, a long-acting recombinant growth hormone analog.

Somatrogon is a modified protein that interacts with growth hormone receptors and influences downstream signaling involving insulin-like growth factor 1 (IGF-1).

The molecular structure of somatrogon differs from conventional somatropin, allowing Ngenla to be administered on a once-weekly schedule rather than the daily schedules associated with many traditional somatropin products.

Somatrogon and somatropin should not be considered identical substances. Their pharmaceutical formulations, pharmacokinetic characteristics and dosing units differ.

Pfizer Ngenla 60 mg Prefilled Injection Pen

Ngenla 60 mg is supplied as a clear, colorless to slightly light-yellow solution in a disposable prefilled injection pen intended for use by a single patient.

The pen contains multiple prescribed doses of somatrogon. The total 60 mg content does not represent a single injection dose.

Ngenla 60 mg Pen Characteristics

• 60 mg total somatrogon-ghla content
• 1.2 ml total solution volume
• 50 mg/ml concentration
• Disposable, single-patient-use pen
• Adjustable dose settings in 0.5 mg increments
• Maximum 30 mg per individual injection
• Blue pen cap, injection button and labeling in the US presentation
• Compatible injection needles required separately

Pfizer's standard US package contains one prefilled pen. Sterile injection needles are required but are not included.

Device preparation, injection technique and needle compatibility are described in the official Pfizer Instructions for Use.

Ngenla 60 mg vs Ngenla 24 mg: Presentation and Comparison

Pfizer offers Ngenla in two prefilled pen strengths: 24 mg/1.2 ml and 60 mg/1.2 ml.

Ngenla 60 mg/1.2 ml

• 60 mg somatrogon-ghla per pen
• 50 mg/ml concentration
• 1.2 ml solution volume
• 0.5 mg dose increments
• 30 mg maximum single injection
• Blue pen components

Ngenla 24 mg/1.2 ml

• 24 mg somatrogon-ghla per pen
• 20 mg/ml concentration
• 1.2 ml solution volume
• 0.2 mg dose increments
• 12 mg maximum single injection
• Lilac pen components

Both presentations contain the same active ingredient but differ in strength, concentration, dose increments and pen identification.

The legacy catalog designations "180IU" and "72IU" should not be used to calculate treatment doses or convert somatrogon milligrams into somatropin international units.

Ngenla Somatrogon vs Conventional Somatropin HGH

Ngenla and conventional somatropin formulations both act on the growth hormone receptor pathway, but they contain different recombinant proteins.

Somatrogon-ghla

Somatrogon-ghla is the active ingredient in Ngenla. It is a long-acting growth hormone analog designed for once-weekly administration.

Somatropin

Somatropin is recombinant human growth hormone with the same amino acid sequence as naturally occurring human growth hormone. Many somatropin formulations require daily administration.

Differences in molecular structure, pharmacokinetics and clinical dosing mean that the strengths of these medications cannot be compared using simple IU conversions.

Ngenla 60 mg Clinical Information

In the United States, Ngenla is indicated for treatment of pediatric patients aged 3 years and older with growth failure due to inadequate secretion of endogenous growth hormone.

Ngenla is administered by subcutaneous injection on a once-weekly schedule when prescribed by an appropriately qualified healthcare professional.

Treatment is individualized according to the patient's medical condition, body weight, growth response and clinical monitoring.

The total 60 mg content of the pen should not be interpreted as a recommended individual dose.

Ngenla 60 mg Storage and Handling

Ngenla is a temperature-sensitive biological medication requiring refrigerated storage.

According to Pfizer's US manufacturer instructions:

• Store unopened pens refrigerated at 2°C–8°C.
• Keep the pen in its original carton to protect it from light.
• Do not freeze or shake the medication.
• After first use, store the pen refrigerated between injections.
• The pen may be used for up to 28 days after first use when stored according to the manufacturer instructions.
• Remove and safely discard the needle after each injection.
• Never store the pen with an injection needle attached.

Follow the product-specific instructions supplied with the actual Ngenla pen.

Ngenla Somatrogon Safety and Precautions

Ngenla is a prescription growth hormone medication that requires clinical supervision.

Potential adverse reactions include injection-site reactions, headache, changes in glucose regulation and other treatment-related effects.

Important contraindications and precautions are described in Pfizer's prescribing information, including active malignancy, certain acute critical illnesses, severe diabetic retinopathy and hypersensitivity to the product.

Medical treatment decisions and monitoring requirements should be established by an appropriately qualified healthcare professional.

Ngenla 60 mg Packaging and Documentation

Review the original product photographs below the main image to examine the Pfizer Ngenla packaging, pen presentation and manufacturer labeling associated with this listing.

Important product identification details include:

• Ngenla brand name
• Pfizer manufacturer identification
• Somatrogon-ghla active ingredient
• Official strength: 60 mg/1.2 ml
• Concentration: 50 mg/ml
• Prefilled injection pen presentation
• Blue pen components in the US presentation
• Batch or lot number
• Expiration date
• Original package integrity
• Manufacturer Instructions for Use
• Available product-specific documentation

The legacy "180IU" designation identifies the historical catalog entry but is not the official Pfizer strength or a recognized treatment equivalence.

Historical product photographs, sample reports or laboratory documents should not be treated as verification of a different supplied batch.

Official prescribing information and device instructions are available from Pfizer Medical Information – Ngenla.

Frequently Asked Questions About Ngenla 60 mg Pen

What is Ngenla 60 mg Pen?

Ngenla 60 mg Pen is a Pfizer prefilled injection device containing 60 mg of somatrogon-ghla in 1.2 ml of solution. It is a long-acting growth hormone analog used in prescribed treatment of pediatric growth hormone deficiency.

Who manufactures Ngenla 60 mg?

Ngenla is a Pfizer pharmaceutical product containing somatrogon-ghla.

What is the active ingredient in Ngenla?

The active ingredient is somatrogon-ghla, a recombinant long-acting growth hormone analog.

How much somatrogon is in Ngenla 60 mg?

Each prefilled pen contains 60 mg of somatrogon-ghla in 1.2 ml of solution, providing a concentration of 50 mg/ml.

Is Ngenla 180IU the same as Ngenla 60 mg?

The term "Ngenla 180IU" is a legacy catalog designation associated with the 60 mg presentation. Pfizer officially labels the product in milligrams, not IU. The legacy term is not a valid dosing conversion.

Is Ngenla the same as somatropin?

No. Ngenla contains somatrogon-ghla, a long-acting growth hormone analog. Conventional somatropin is a different recombinant protein with distinct dosing characteristics.

What is the difference between Ngenla 60 mg and 24 mg?

Ngenla 60 mg contains 60 mg in 1.2 ml at 50 mg/ml concentration, while Ngenla 24 mg contains 24 mg in 1.2 ml at 20 mg/ml concentration. The pens also have different dose increments and maximum single-injection settings.

Is Ngenla administered once weekly?

Yes. Ngenla is designed for once-weekly administration when prescribed for an approved medical indication.

What is the maximum single injection from Ngenla 60 mg Pen?

The Ngenla 60 mg pen allows a maximum setting of 30 mg per single injection. This is a device specification, not a recommended treatment dose.

Does Ngenla 60 mg include injection needles?

Pfizer's standard US package contains a prefilled pen without injection needles. Compatible sterile needles must be obtained separately.

How should Ngenla 60 mg be stored?

Store refrigerated at 2°C–8°C and protect from light. Do not freeze or shake. Follow Pfizer's handling instructions before and after first use.

How long can Ngenla 60 mg be used after first use?

Pfizer's US instructions specify a maximum of 28 days after first use when the pen is stored and handled according to the manufacturer requirements.

What information should be verified on the Ngenla package?

Check the Pfizer label, somatrogon-ghla ingredient, 60 mg/1.2 ml strength, batch number, expiration date, package integrity and manufacturer Instructions for Use.

How can I request information about Ngenla 60 mg Pen?

Use the form on this page. The product is attached automatically. Enter your name, country, email and number of packages, and specify any questions about packaging, labeling or available documentation.

Related Product Guides

• Ngenla Pen – 72IU Catalog Listing (24 mg/1.2 ml)
• Hutrope LinePen 30IU HGH